Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
- Conditions
- AML
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 36
- Registration Number
- NCT01184898
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Reduced Intensity Haploidentical Transplant for Hematological Malignancies
- Conditions
- Hematological Malignancies
- First Posted Date
- 2010-07-14
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 34
- Registration Number
- NCT01162096
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Digoxin for Recurrent Prostate Cancer
- First Posted Date
- 2010-07-14
- Last Posted Date
- 2025-05-04
- Target Recruit Count
- 16
- Registration Number
- NCT01162135
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
- Conditions
- High Risk Non-Hodgkin's Lymphoma
- Interventions
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 11
- Registration Number
- NCT00994643
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
- Conditions
- Carcinoma, Non-small-cell Lung
- Interventions
- Radiation: Hypofractionated Radiotherapy
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 17
- Registration Number
- NCT00983307
- Locations
- 🇺🇸
Northeast Radiation Oncology Center, Dunmore, Pennsylvania, United States
🇺🇸Thomas Jefferson Univeristy, Philadelphia, Pennsylvania, United States
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
- Conditions
- Metastatic Pancreatic Cancer
- Interventions
- Dietary Supplement: Intravenous Vitamin C
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 14
- Registration Number
- NCT00954525
- Locations
- 🇺🇸
Jefferson-Myrna Brind Center of Integrative Medicine, Philadelphia, Pennsylvania, United States
Fatigue and Pancreas and Bile Duct Cancer Study
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 100
- Registration Number
- NCT00902759
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2013-12-18
- Target Recruit Count
- 120
- Registration Number
- NCT00898690
Increasing Colorectal Cancer Screening in African Americans
- Conditions
- Colorectal Cancer
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2013-12-18
- Target Recruit Count
- 896
- Registration Number
- NCT00893295
- Locations
- 🇺🇸
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
- First Posted Date
- 2009-02-09
- Last Posted Date
- 2025-05-04
- Target Recruit Count
- 17
- Registration Number
- NCT00838929
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸The University of Texas Southwestern Medical Center, Dallas, Texas, United States